Back to Search Start Over

Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors :
Bowers DC
Verbruggen LC
Kremer LCM
Hudson MM
Skinner R
Constine LS
Sabin ND
Bhangoo R
Haupt R
Hawkins MM
Jenkinson H
Khan RB
Klimo P Jr
Pretorius P
Ng A
Reulen RC
Ronckers CM
Sadighi Z
Scheinemann K
Schouten-van Meeteren N
Sugden E
Teepen JC
Ullrich NJ
Walter A
Wallace WH
Oeffinger KC
Armstrong GT
van der Pal HJH
Mulder RL
Source :
The Lancet. Oncology [Lancet Oncol] 2021 May; Vol. 22 (5), pp. e196-e206. Date of Electronic Publication: 2021 Apr 09.
Publication Year :
2021

Abstract

Exposure to cranial radiotherapy is associated with an increased risk of subsequent CNS neoplasms among childhood, adolescent, and young adult (CAYA) cancer survivors. Surveillance for subsequent neoplasms can translate into early diagnoses and interventions that could improve cancer survivors' health and quality of life. The practice guideline presented here by the International Late Effects of Childhood Cancer Guideline Harmonization Group was developed with an evidence-based method that entailed the gathering and appraisal of published evidence associated with subsequent CNS neoplasms among CAYA cancer survivors. The preparation of these guidelines showed a paucity of high-quality evidence and highlighted the need for additional research to inform survivorship care. The recommendations are based on careful consideration of the evidence supporting the benefits, risks, and harms of the surveillance interventions, clinical judgment regarding individual patient circumstances, and the need to maintain flexibility of application across different health-care systems. Currently, there is insufficient evidence to establish whether early detection of subsequent CNS neoplasms reduces morbidity and mortality, and therefore no recommendation can be formulated for or against routine MRI surveillance. The decision to start surveillance should be made by the CAYA cancer survivor and health-care provider after careful consideration of the potential harms and benefits of surveillance for CNS neoplasms, including meningioma.<br />Competing Interests: Declaration of interests We declare no competing interests.<br /> (Copyright © 2021 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1474-5488
Volume :
22
Issue :
5
Database :
MEDLINE
Journal :
The Lancet. Oncology
Publication Type :
Academic Journal
Accession number :
33845037
Full Text :
https://doi.org/10.1016/S1470-2045(20)30688-4